Difference between revisions of "Team:Uppsala/Phage Display"

Line 303: Line 303:
 
<h1>Experiment</h1>
 
<h1>Experiment</h1>
 
<p>
 
<p>
There are no readily available protocols for whole-organism exterior screenings using phage display, to read more closely what how we adapted this procedure to fit our needs read more here:
+
There are no readily available protocols for whole-organism exterior screenings using phage display, to read more closely what how we adapted this procedure to fit our needs read more here.
 
<br>
 
<br>
 
<br>
 
<br>
Line 316: Line 316:
 
<br>
 
<br>
 
<br>
 
<br>
Read more about our modified protocol here:
+
Read more about our modified protocol here.
 
</p>
 
</p>
  
Line 324: Line 324:
 
<h1>Results</h1>
 
<h1>Results</h1>
 
<p>
 
<p>
INTRO TEXT ABOUT OUR RESULTS - ots and lots and lots and lots of example text...  Lots and lots and lots and lots of example text... Lots and lots and lots and lots of example text...  Lots and lots and lots and lots of example text... Lots and lots and lots and lots of example text...  Lots and lots and lots and lots of example text... Lots and lots and lots and lots of example text...  Lots and lots and lots and lots of example text... Lots and lots and lots and lots of example text...  Lots and lots and lots and lots of example text... Lots and lots and lots and lots of example text...  Lots and lots and lots and lots of example text...
+
Our three parallell pannings and subsequent analysis led to the following peptides being characterized:
 +
</p>
 +
<div>
 
<br>
 
<br>
<br>
+
<p><strong>Table 1:</strong> Final peptides and their characteristics. *TUP = Target-Unrelated Peptide.
Read more:
+
 
</p>
 
</p>
 +
<table class="wikitable">
 +
<tbody>
 +
<tr>
 +
<th>
 +
</th>
 +
<th> Sample
 +
</th>
 +
<th> Aligned Sequence
 +
</th>
 +
<th> Propagation Advantage
 +
</th>
 +
<th>Predicted Polysterene Binder
 +
</th>
 +
<th> Known TUP*-Motif
 +
</th>
 +
</tr>
  
 +
<tr>
 +
<th> Series 1:
 +
</th>
 +
<th> EF01122224: TPIFLPTPAQEH
 +
</th>
 +
<th> TP<span class="blue-letter">I</span>FL<span class="red-letter">P</span>TPA<span class="blue-letter">Q</span>EH---
 +
</th>
 +
<th>Yes
 +
</th>
 +
<th>No
 +
</th>
 +
<th>No
 +
</th>
 +
</tr>
 +
 +
 +
<tr>
 +
<th> Series 3:
 +
</th>
 +
<th> EF01122218: FSPTQANTIHRW
 +
</th>
 +
<th> ---FS<span class="red-letter">P</span>TQA<span class="blue-letter">N</span>T<span class="blue-letter">IH</span>RW
 +
</th>
 +
<th>No
 +
</th>
 +
<th>No
 +
</th>
 +
<th>No
 +
</th>
 +
</tr>
 +
 +
<tr>
 +
<th>
 +
</th>
 +
<th> EF01122220: VGGTVQSESHRR
 +
</th>
 +
<th>--<span class="blue-letter">V</span>GGTVQSESH<span class="blue-letter">R</span>R-
 +
</th>
 +
<th>No
 +
</th>
 +
<th>No
 +
</th>
 +
<th>No
 +
</th>
 +
</tr>
 +
 +
<tr>
 +
<th>
 +
</th>
 +
<th> EF01122222: SMGRTDYVQQLR
 +
</th>
 +
<th>-S<span class="blue-letter">M</span>GRTDYV<span class="blue-letter">Q</span>Q<span class="blue-letter">LR</span>--
 +
</th>
 +
<th>No
 +
</th>
 +
<th>No
 +
</th>
 +
<th>No
 +
</th>
 +
</tr>
 +
 +
<tr>
 +
<th>
 +
</th>
 +
<th> EF01122217: RVQPAHFNVMGQ
 +
</th>
 +
<th>--RVQ<span class="red-letter">P</span>AHF<span class="blue-letter">N</span>V<span class="blue-letter">M</span>GQ
 +
</th>
 +
<th>No
 +
</th>
 +
<th>Yes
 +
</th>
 +
<th>No
 +
</th>
 +
</tr>
 +
 +
</table>
 +
</div>
 
</div>
 
</div>
  

Revision as of 23:16, 15 October 2018